The National Agency for Food and Drug Administration and Control has approved AstraZeneca COVID-19 vaccine for use in Nigeria.
NAFDAC in a press briefing said it got the dossier of the vaccine a week ago.
The drug agency stated that the safety committee went to work immediately to evaluate the vaccine safety and efficacy for Nigerians.
The Oxford/AstraZeneca vaccine, also known as ChAdOx1 nCoV-19, or AZD1222, is a viral vector vaccine.
Scientists used an adenovirus, originally derived from chimpanzees, and modified it with the aim of training the immune system to mount a strong response against SARS-CoV-2 (the virus that causes COVID-19).
The vaccine can be stored at 2-8? ( in a normal refrigerator) which distinguished it from some of the other COVID-19 vaccines such as Pfizer’s mRNA vaccine.